Technology | July 11, 2014

Toshiba Introduces New MR Software for More Efficient Exams

Automated tools for Vantage Titan 1.5T and 3T MR customers with M-Power enhance productivity

July 11, 2014 — Toshiba America Medical Systems introduced its newest M-Power software version for the Vantage Titan 1.5T magnetic resonance (MR) system and a new software version for its Vantage Titan 3T MR. Toshiba will also offer the new software versions with enhanced automated tools at no charge to existing Titan customers with previous M-Power software versions that have a current service contract with Toshiba.

The new software versions for the Titan 1.5T and 3T MR systems feature several workflow enhancements and new clinical applications:

  • M-Power’s PathFinder: Improved automated tools to streamline exams and workflow efficiencies, including DirectPAS, EasyTech and InScan.
  • 3-D Arterial Spin Labeling (ASL): Clinically enhanced non-contrast suite with 3-D ASL non-contrast perfusion for the whole brain.
  • DelayTracker: Automation of delay times for non-contrast Fresh Blood Imaging from renal to feet vessels.
  • 3-D Spectroscopy (Optional): Improved functionality to perform 3-D spectroscopy, including during prostate imaging.
  • 3-D Gradient Distortion Correction: Features capabilities for 3-D correction of image distortions and is only available for the Titan 3T MR.

“Toshiba puts customers’ business needs first when developing software advancements so that healthcare providers can deliver the best patient experience with the latest technology available,” said Beverly Plost, director, MR Business Unit, Toshiba. “The M-Power software for Toshiba’s Titan 1.5T and Titan 3T MR includes enhancements to a comprehensive suite of innovative applications for faster and easier exams.”

For more information:

Related Content

FDA Clears CereMetrix’s Neuroimaging Analytics and Clinical Workflow Platform
Technology | Neuro Imaging | March 15, 2018
March 15, 2018 – CereMetrix, a subsidiary of CereHealth Corp., ha
Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Alternative Technique Can Improve Brain Imaging for Restless Children
News | Pediatric Imaging | March 08, 2018
March 8, 2018 – Children often find it difficult to remain still for...
The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain.

This figure shows two different brains that are aligned to a common template space for comparison. The yellow in the anterolateral entorhinal cortex of the young brain indicates significant activity, something that is absent in the older brain. CREDIT: Zachariah Reagh

News | Nuclear Imaging | March 08, 2018
As we get older, it's not uncommon to experience "senior moments," in which we forget where we parked our car or call...
Imaging Plays Key Role in Evaluating Injuries at Olympics
News | Orthopedic Imaging | February 28, 2018
The Olympic Games give elite athletes a chance at athletic triumph, but also carry a risk of injury. When injuries...
ContextVision Demonstrates VolarView and the Orthopedic Package at ECR 2018
Technology | Advanced Visualization | February 27, 2018
At this year’s European Congress of Radiology (ECR), Feb. 28-March 4 in Vienna, Austria, ContextVision will showcase...
Aidoc Introduces AI Solution for Whole-Body CT Scan Analysis
News | Artificial Intelligence | February 20, 2018
Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Overlay Init